Korro Bio ROA 2018-2024 | KRRO

Current and historical return on assets (ROA) values for Korro Bio (KRRO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Korro Bio ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-03-31 $-0.08B $0.20B -60.18%
2023-12-31 $-0.08B $0.22B -73.05%
2023-09-30 $-0.04B $0.05B -49.17%
2023-06-30 $-0.05B $0.08B -46.04%
2023-03-31 $-0.06B $0.10B -47.62%
2022-12-31 $-0.06B $0.07B -44.19%
2022-09-30 $-0.09B $0.14B -54.09%
2022-06-30 $-0.09B $0.15B -51.85%
2022-03-31 $-0.09B $0.17B -45.60%
2021-12-31 $-0.09B $0.19B -40.05%
2021-09-30 $-0.07B $0.20B -31.43%
2021-06-30 $-0.05B $0.22B -22.06%
2021-03-31 $-0.04B $0.24B -17.34%
2020-12-31 $-0.03B $0.27B -11.30%
2020-09-30 $-0.02B $0.23B -10.02%
2020-06-30 $-0.02B $0.21B -9.33%
2020-03-31 $-0.02B $0.22B -13.11%
2019-12-31 $-0.02B $0.22B -21.32%
2019-06-30 $-0.02B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.307B $0.014B
Korro Bio Inc. is an RNA editing company focused on the discovery and development of a new class of precision genetic medicines for both rare and highly prevalent diseases. Korro Bio Inc., formerly known as Frequency Therapeutics Inc., is based in LEXINGTON, Mass.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.765B 32.43
Chugai Pharmaceutical (CHGCY) Japan $59.121B 26.43
Takeda Pharmaceutical (TAK) Japan $41.238B 8.35
Merck (MKGAF) Germany $20.490B 19.87
Astellas Pharma (ALPMY) Japan $17.771B 28.06
Sandoz Group AG (SDZNY) Switzerland $15.447B 0.00
United Therapeutics (UTHR) United States $14.063B 14.99
Neurocrine Biosciences (NBIX) United States $13.837B 37.88
Shionogi (SGIOY) Japan $11.399B 9.91
Catalent (CTLT) United States $10.171B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.512B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.627B 7.28
Ionis Pharmaceuticals (IONS) United States $6.589B 0.00
Revolution Medicines (RVMD) United States $6.167B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Madrigal Pharmaceuticals (MDGL) United States $5.790B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Summit Therapeutics (SMMT) United States $5.293B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.591B 0.00
Corcept Therapeutics (CORT) United States $3.286B 29.77
Arrowhead Pharmaceuticals (ARWR) United States $3.132B 0.00
Dyne Therapeutics (DYN) United States $3.028B 0.00
PTC Therapeutics (PTCT) United States $2.331B 0.00
Indivior (INDV) United States $2.105B 9.98
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.019B 11.47
Catalyst Pharmaceuticals (CPRX) United States $1.866B 18.16
NewAmsterdam Pharma (NAMS) Netherlands $1.827B 0.00
Evotec AG (EVO) Germany $1.754B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.702B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.352B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.335B 0.00
Soleno Therapeutics (SLNO) United States $1.327B 0.00
Ardelyx (ARDX) United States $1.229B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.154B 0.00
Xencor (XNCR) United States $1.126B 0.00
4D Molecular Therapeutics (FDMT) United States $1.064B 0.00
Pacira BioSciences (PCRX) United States $1.058B 10.06
Collegium Pharmaceutical (COLL) United States $1.048B 6.27
Ocular Therapeutix (OCUL) United States $1.035B 0.00
Enliven Therapeutics (ELVN) United States $1.021B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.974B 15.17
Centessa Pharmaceuticals (CNTA) United Kingdom $0.881B 0.00
Cronos Group (CRON) Canada $0.868B 0.00
Relay Therapeutics (RLAY) United States $0.859B 0.00
USANA Health Sciences (USNA) United States $0.856B 14.00
ARS Pharmaceuticals (SPRY) United States $0.839B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.775B 0.00
Harrow (HROW) United States $0.738B 0.00
Sage Therapeutics (SAGE) United States $0.651B 0.00
Exscientia (EXAI) United Kingdom $0.617B 0.00
Savara (SVRA) United States $0.594B 0.00
Cassava Sciences (SAVA) United States $0.566B 0.00
Siga Technologies (SIGA) United States $0.555B 7.09
Silence Therapeutics (SLN) United Kingdom $0.541B 0.00
ProKidney (PROK) United States $0.514B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.513B 0.00
Larimar Therapeutics (LRMR) United States $0.492B 0.00
KalVista Pharmaceuticals (KALV) United States $0.486B 0.00
Altimmune (ALT) United States $0.478B 0.00
Lexeo Therapeutics (LXEO) United States $0.462B 0.00
Bioventus (BVS) United States $0.458B 17.51
Esperion Therapeutics (ESPR) United States $0.443B 0.00
OmniAb (OABI) United States $0.432B 0.00
Verve Therapeutics (VERV) United States $0.420B 0.00
Heron Therapeutics (HRTX) United States $0.413B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.405B 0.00
Lyell Immunopharma (LYEL) United States $0.385B 0.00
Organogenesis (ORGO) United States $0.353B 66.50
Tourmaline Bio (TRML) United States $0.322B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.317B 0.00
Xeris Biopharma Holdings (XERS) United States $0.305B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.285B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 17.88
Nanobiotix S.A (NBTX) France $0.247B 0.00
Black Diamond Therapeutics (BDTX) United States $0.237B 0.00
Foghorn Therapeutics (FHTX) United States $0.232B 0.00
Aquestive Therapeutics (AQST) United States $0.220B 0.00
ESSA Pharma (EPIX) Canada $0.219B 0.00
Nektar Therapeutics (NKTR) United States $0.215B 0.00
Fractyl Health (GUTS) United States $0.213B 0.00
Profound Medical (PROF) Canada $0.210B 0.00
Prelude Therapeutics (PRLD) United States $0.205B 0.00
Avita Medical (RCEL) United States $0.203B 0.00
Eliem Therapeutics (ELYM) United States $0.203B 0.00
Akebia Therapeutics (AKBA) United States $0.201B 0.00
Elite Pharmaceuticals (ELTP) United States $0.200B 18.70
Innate Pharma SA (IPHYF) France $0.200B 0.00
Aldeyra Therapeutics (ALDX) United States $0.193B 0.00
Acrivon Therapeutics (ACRV) United States $0.188B 0.00
Century Therapeutics (IPSC) United States $0.187B 0.00
Incannex Healthcare (IXHL) Australia $0.184B 0.00
Zevra Therapeutics (ZVRA) United States $0.182B 0.00
Pyxis Oncology (PYXS) United States $0.173B 0.00
Metagenomi (MGX) United States $0.158B 0.00
Achieve Life Sciences (ACHV) Canada $0.158B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.148B 0.00
MediWound (MDWD) Israel $0.144B 0.00
Galectin Therapeutics (GALT) United States $0.142B 0.00
CytoDyn (CYDY) United States $0.139B 0.00
Context Therapeutics (CNTX) United States $0.138B 0.00
Cardiol Therapeutics (CRDL) Canada $0.135B 0.00
Telomir Pharmaceuticals (TELO) United States $0.120B 0.00
VAXART, INC (VXRT) United States $0.120B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.118B 7.91
OptiNose (OPTN) United States $0.118B 0.00
Regulus Therapeutics (RGLS) United States $0.115B 0.00
Assertio Holdings (ASRT) United States $0.109B 5.00
Journey Medical (DERM) United States $0.105B 0.00
Karyopharm Therapeutics (KPTI) United States $0.100B 0.00
Citius Pharmaceuticals (CTXR) United States $0.093B 0.00
Relmada Therapeutics (RLMD) United States $0.090B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.087B 0.00
AlloVir (ALVR) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.081B 0.00
PMV Pharmaceuticals (PMVP) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.077B 0.00
FibroGen (FGEN) United States $0.074B 0.00
SCYNEXIS (SCYX) United States $0.074B 1.04
CASI Pharmaceuticals (CASI) China $0.073B 0.00
ProPhase Labs (PRPH) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.067B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.065B 0.00
Nutriband (NTRB) United States $0.065B 0.00
Conduit Pharmaceuticals (CDT) United States $0.065B 0.00
Carisma Therapeutics (CARM) United States $0.060B 0.00
Mural Oncology (MURA) Ireland $0.052B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.050B 0.00
Tempest Therapeutics (TPST) United States $0.047B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.047B 0.00
BioLineRx (BLRX) Israel $0.043B 0.00
DURECT (DRRX) United States $0.042B 0.00
Inotiv (NOTV) United States $0.042B 0.00
Protara Therapeutics (TARA) United States $0.042B 0.00
Lipocine (LPCN) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
Natural Alternatives (NAII) United States $0.034B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.030B 0.00
NRx Pharmaceuticals (NRXP) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
VYNE Therapeutics (VYNE) United States $0.026B 0.00
BioVie (BIVI) United States $0.025B 0.00
Gain Therapeutics (GANX) United States $0.022B 0.00
Minerva Neurosciences (NERV) United States $0.022B 0.00
Oncternal Therapeutics (ONCT) United States $0.021B 0.00
Aptorum Group (APM) United Kingdom $0.021B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Viracta Therapeutics (VIRX) United States $0.019B 0.00
PolyPid (PYPD) Israel $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.019B 0.71
Indaptus Therapeutics (INDP) United States $0.018B 0.00
JanOne (JAN) United States $0.018B 0.00
Iterum Therapeutics (ITRM) Ireland $0.018B 0.00
Unicycive Therapeutics (UNCY) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Cosmos Health (COSM) Greece $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.017B 0.00
Jaguar Animal Health (JAGX) United States $0.017B 0.00
Talphera (TLPH) United States $0.016B 0.00
SHINECO (SISI) China $0.014B 0.00
Mannatech (MTEX) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Universe Pharmaceuticals INC (UPC) China $0.011B 0.00
Alaunos Therapeutics (TCRT) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Ainos (AIMD) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.81
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 30.51